AVITA Medical, Inc. (RCEL) income statement
RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$16.83+1.06 (+6.72%)
Close on Nov 18, 2026Market cap $520.50MP/E –Yield –
AVITA Medical, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 81.6%
- Operating margin
- -46.6%
- Net margin
- -57.0%
- Return on equity, FY2025
- 799.7%
Financial strength
- Current ratio
- 0.41
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 13.3%
Valuation
- P/E ratio
- –
- Price to sales
- 6.88
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?